Teicoplanin — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

7 Recruiting

1 Completed trials

9 Sponsors

10 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 2 Phase IV: 3

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Sepsis 2 Abdominal infection 1 Endocarditis enterococcal 1 Cystic fibrosis 1 Urinary tract infection 1 Bacterial infection 1 Antibiotic level therapeutic 1 Infection 1

Sponsors using this IMP

Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 2 Assistance Publique Hopitaux De Paris 1 Azienda Ospedaliera Universitaria Integrata Verona 1 Centre Hospitalier Universitaire De Nantes 1 Friedrich-Schiller-Universitaet Jena 1 Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca 1 Hellenic Institute For The Study Of Sepsis 1 Pfizer Inc. 1 Prinses Maxima Centrum voor Kinderoncologie B.V. 1

All trials

10 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending

2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Recruiting

2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa… Recruiting

2024-517820-21-00 Phase II 1 country Azienda Ospedaliera Universitaria Integrata Verona
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) Recruiting

2023-506546-23-00 Phase III 4 countries Prinses Maxima Centrum voor Kinderoncologie B.V.
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Phase III 1 country Hellenic Institute For The Study Of Sepsis

Showing 1–10 of 10 trials

← All drugs A–Z